Bio Tech

Biotech Accelerator IndieBio Is Convincing Investors to Start Paying Attention to Biotech Startups

San Fransisco-based biotech accelerator IndieBio is determined to help biotech startups the way other accelerators have done for IT startups. The firm believes that biotech is a highly important sector to boost the quality of humanity and economy, and is convincing other investors to have the same vision.


After robust phase, venture capital heads to pre-recession level

Venture capital (VC) funding activity seems to be heading towards pre-recessionary mark. The VC activity recorded robust growth phase for over seven years. The sluggish financial markets are discouraging VC funding and raising money.

Medicxi Ventures, A Spin-off Biotechnology Investment Firm Of Index Ventures Emerges As Largest Of Its Kind In Europe

Index Ventures, known for funding Skype, Dropbox and Candy Crush Saga online game is starting a new biotech venture capital firm named Medicxi Ventures. GlaxoSmithKline Plc. and Johnson & Johnson have funded $230 million to Medicxi Ventrue and would reportedly contribute 25 percent of the investment.

France Based Pharmaceutical Company Sanofi Pasteur Committed To Develop Zika Virus Vaccination

The France-based pharmaceutical company Sanofi Pasteur has committed to develop Zika virus vaccination in three to five years. The vaccine will be administered mainly in adolescent girls that is yet to involve sexual relationship.


Latest News

WHO on Thursday has warned for probable spread of Zika virus across the North and Central American countries. Ahead of rising concerns for Zika spreading, drug makers and scientists have commented that manufacturing of an appropriate vaccine may even require a decade. These warnings has opened a huge business potential for Oxitec, an Intrexon subsidiary. Oxitec’s gene modified mosquitoes are capable of ensuring security against Zika for large populations.
South Korea is famous for its skin care and cosmetic products that use unusual traditional ingredients, including snail slime. This ingredient is said to be very helpful in the skin collagen formation as well as to be used as moisturizer. More and more Korean beauty products enter the U.S. as the demand is also increasing.
Zika virus outbreak is taking a toll on many countries around the world including Brazil which has raised concerns on the spread of infection among US population as well. Oxitec, a british company is set to release GM mosquitoes to contain the insect population in Brazil.
Angelsense is an application that can be used to track the locations of children with autism. Children with autism are often wandering off. With the features in this application, parents can find out where their children are, and also receive alert messages if their children move to unusual locations.
Previously, an experiment team of a space gardening project called Veggie has also succeeded planting consumable lettuce. The flower bloom is a remarkable step forward to a more advanced technique and choice of plants to grow in space. The project was established because NASA seeks to learn how astronauts can grow their own food in space to sustain long-term space journey.
The initial study was conducted with rats, but it was confirmed that the researchers seek to extend the new findings to human. The biodegradable chip was expected to help doctors monitor their patients better while reducing risks of removal re-operation, such as infections.
Previously, the company has also purchased German's KraussMaffei Group. Also, Chinese companies investment overseas is growing.
Biotrial Private Facility has been conducting trial of a pain killer over 90 volunteers. Six of them have fall sick and one of them has got severe brain injury. Volunteers rarely fall sick while undergoing through such trials, since the drug must go through several tests over animals with wide range of dosage. Paris prosecutors have initiated investigations to unearth the cause behind the regulator approved trial.
The FDA advisory panel has approved the use of an implant to help treat patients who are addicted to opiods. The implant will administer the drug slowly over a period of six months, but those opposed to the decision say that there are still problems with the implant that should be addressed before becoming approved for public use.
Investors sue KaloBios Pharmaceuticals Inc. to return $5.4 million of their investment. The investors were brought in by Martin Shkreli. KaloBios Pharmaceuticals Inc. filed for bankruptcy in late December.
  1 2 3 4 5 6 7 8 9 10  
Real Time Analytics